|
*DISCLAIMER*: Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, Frankly and this Station make no warranties or representations in connection therewith.
|
Medicine & Pharmaceuticals News Releases via PRNewswireMore>>
Global Veterinary Diagnostics Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Abaxis, Heska, IDEXX Laboratories, Thermo Fisher Scientific & Zoetis
Global Veterinary Diagnostics Market - Analysis, Technologies & Forecasts to 2021 - Key Vendors are Abaxis, Heska, IDEXX Laboratories, Thermo Fisher Scientific & Zoetis
The "Global Veterinary Diagnostics Market 2017-2021" report has been added to Research and Markets' offering. The global veterinary diagnostics market to grow at a CAGR of 9.11% during the period 2017-2021. The...More \232aThe "Global Veterinary Diagnostics Market 2017-2021" report has been added to Research and Markets' offering. The global veterinary diagnostics market to grow at a CAGR of 9.11% during the period 2017-2021. The...More \232aR&D Drug Pipeline Online Database Subscription
R&D Drug Pipeline Online Database Subscription
The "R&D Drug Pipeline Database" newsletter has been added to Research and Markets' offering. R&D Drug Pipeline Database: 1-Year Subscription Subscription to this proprietary R&D Drug Pipeline Database...More \232aThe "R&D Drug Pipeline Database" newsletter has been added to Research and Markets' offering. R&D Drug Pipeline Database: 1-Year Subscription Subscription to this proprietary R&D Drug Pipeline Database...More \232aOnline R&D and Business Tracker for Bispecific Antibodies
Online R&D and Business Tracker for Bispecific Antibodies
The "R&D and Business Tracker for Bispecific Antibodies" newsletter has been added to Research and Markets' offering. This information service about Bispecific Antibodies delivers 12 monthly update reports in pdf...More \232aThe "R&D and Business Tracker for Bispecific Antibodies" newsletter has been added to Research and Markets' offering. This information service about Bispecific Antibodies delivers 12 monthly update reports in pdf...More \232aNeuroprosthetics Markets, 2028 - Market Could Reach $18 Billion
Neuroprosthetics Markets, 2028 - Market Could Reach $18 Billion
The "Neuroprosthetics 2018-2028: Technologies, Forecasts, Players" report has been added to Research and Markets' offering. This report covers the competitive landscape for cochlear implants, retinal implants, and...More \232aThe "Neuroprosthetics 2018-2028: Technologies, Forecasts, Players" report has been added to Research and Markets' offering. This report covers the competitive landscape for cochlear implants, retinal implants, and...More \232aRepatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine
Repatha® (Evolocumab) Phase 3 Cognitive Function Study Results Published In The New England Journal Of Medicine
Amgen (NASDAQ:AMGN) today announced that the New England Journal of Medicine (NEJM) published results from the Repatha® (evolocumab) cognitive function trial (EBBINGHAUS), which was conducted in a subset of patients...More \232aAmgen (NASDAQ:AMGN) today announced that the New England Journal of Medicine (NEJM) published results from the Repatha® (evolocumab) cognitive function trial (EBBINGHAUS), which was conducted in a subset of patients...More \232aGlobal Biologics Market Analysis and Forecast 2017-2025 - Focus on Pipeline Analysis, Product Type, Therapeutic Application
Global Biologics Market Analysis and Forecast 2017-2025 - Focus on Pipeline Analysis, Product Type, Therapeutic Application
The "Global Biologics Market - Analysis and Forecast (2017-2025) (Focus on Pipeline Analysis, Product Type, Therapeutic Application, Country Analysis, and Market Dynamics)" report has been added to Research and...More \232aThe "Global Biologics Market - Analysis and Forecast (2017-2025) (Focus on Pipeline Analysis, Product Type, Therapeutic Application, Country Analysis, and Market Dynamics)" report has been added to Research and...More \232aKitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
Kitov Pharmaceuticals Provides Corporate Update and Reports First Half 2017 Financial Results
Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV) (TASE: KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported financial results for the first half of 2017, ending June 30, 2017.More \232aKitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV) (TASE: KTOV), an innovative biopharmaceutical company, today provided a corporate update and reported financial results for the first half of 2017, ending June 30, 2017.More \232aAvella Specialty Pharmacy again named one of Inc. 5000's Fastest Growing Companies
Avella Specialty Pharmacy again named one of Inc. 5000's Fastest Growing Companies
Avella Specialty Pharmacy has once again been designated one of Inc. Magazine's 5,000 fastest growing companies in America. Avella has received this honor each of the last 11 years, validating the company's...More \232aAvella Specialty Pharmacy has once again been designated one of Inc. Magazine's 5,000 fastest growing companies in America. Avella has received this honor each of the last 11 years, validating the company's...More \232aL.E.A.F. Pharmaceuticals Establishes its First Subsidiary in Rwanda
L.E.A.F. Pharmaceuticals Establishes its First Subsidiary in Rwanda
L.E.A.F. Pharmaceuticals LLC, a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to discover, develop and commercialize innovative and safe therapies for cancer,...More \232aL.E.A.F. Pharmaceuticals LLC, a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to discover, develop and commercialize innovative and safe therapies for cancer,...More \232aGlobal Orthopedics Devices Market Analysis and Forecast 2017-2023 with Emphasis on China - Market is Expected to Reach $61 Billion
Global Orthopedics Devices Market Analysis and Forecast 2017-2023 with Emphasis on China - Market is Expected to Reach $61 Billion
The "Global Orthopedics Devices Market - Analysis and Forecast (2017-2023) (Focus on China Market, Market Share Analysis, Competitive Landscape, Material, Product, Country Analysis, and End User)" report has been added to...More \232aThe "Global Orthopedics Devices Market - Analysis and Forecast (2017-2023) (Focus on China Market, Market Share Analysis, Competitive Landscape, Material, Product, Country Analysis, and End User)" report has been added to...More \232aGlobal Operating Room Cameras Market 2017-2021 - Latest Trend Gaining Momentum in the Market is Growing Popularity of Hybrid ORs
Global Operating Room Cameras Market 2017-2021 - Latest Trend Gaining Momentum in the Market is Growing Popularity of Hybrid ORs
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliatedMore \232aInformation contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliatedMore \232aRenowned Liver Disease Specialist Named Director of Hepatology at NYU Langone Health
Renowned Liver Disease Specialist Named Director of Hepatology at NYU Langone Health
Ira Jacobson, MD, an internationally renowned hepatology and liver disease expert, has joined NYU Langone Health as its new director of hepatology within the Division of Gastroenterology.More \232aIra Jacobson, MD, an internationally renowned hepatology and liver disease expert, has joined NYU Langone Health as its new director of hepatology within the Division of Gastroenterology.More \232apMD Makes Inc. 5000 List 6 Years in a Row!
pMD Makes Inc. 5000 List 6 Years in a Row!
Each year, Inc. ranks the fastest-growing private companies in America. pMD, the innovation leader in health care technology, is delighted to be acknowledged on this prestigious list for the sixth consecutive year. pMD is...More \232aEach year, Inc. ranks the fastest-growing private companies in America. pMD, the innovation leader in health care technology, is delighted to be acknowledged on this prestigious list for the sixth consecutive year. pMD is...More \232a(IOLs) Intraocular Lens Market Analysis Industry Manufacturers, Application, Future Trends and Forecasts to 2022 in New Research Report at ReportsnReports
(IOLs) Intraocular Lens Market Analysis Industry Manufacturers, Application, Future Trends and Forecasts to 2022 in New Research Report at ReportsnReports
Intraocular Lens (IOLs) market report outlines the evolution of Intraocular Lens (IOLs) market by type and applications and identifies and assesses the best performing vendors in the market to 2022.Intraocular Lens (IOLs)...More \232aIntraocular Lens (IOLs) market report outlines the evolution of Intraocular Lens (IOLs) market by type and applications and identifies and assesses the best performing vendors in the market to 2022.Intraocular Lens (IOLs)...More \232aColorado Access and Amitech: Trailblazing Big Data Analytics Critical to Healthcare Transformation in Medicaid
Colorado Access and Amitech: Trailblazing Big Data Analytics Critical to Healthcare Transformation in Medicaid
Colorado Access (COA) has tapped health care data analytics consulting firm Amitech Solutions to rebuild their data management and analytics infrastructure from the ground up. With this ambitious project, they will be at...More \232aColorado Access (COA) has tapped health care data analytics consulting firm Amitech Solutions to rebuild their data management and analytics infrastructure from the ground up. With this ambitious project, they will be at...More \232aGlobal Alzheimer's Disease Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments
Global Alzheimer's Disease Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments
The "Alzheimer's Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments" report has been added to Research and Markets' offering. Although...More \232aThe "Alzheimer's Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments" report has been added to Research and Markets' offering. Although...More \232aKingfisher Talent and Virdis Group Announce Global Executive Search Collaboration
Kingfisher Talent and Virdis Group Announce Global Executive Search Collaboration
Kingfisher Talent, the Boston-based consortium for biotech executive search and leadership development, and Virdis Group, global executive search specialists in the Life-Science and Healthcare sectors, have created an...More \232aKingfisher Talent, the Boston-based consortium for biotech executive search and leadership development, and Virdis Group, global executive search specialists in the Life-Science and Healthcare sectors, have created an...More \232aThe Ongoing MRSA Epidemic Continues to be Ignored
The Ongoing MRSA Epidemic Continues to be Ignored
Antimicrobial resistance (AMR) is a current and dangerous global public health crisis. "The ongoing MRSA (Methicillin-resistant Staphyloccocus aureus) epidemic is fueling antibiotic resistance globally and MRSA infections...More \232aAntimicrobial resistance (AMR) is a current and dangerous global public health crisis. "The ongoing MRSA (Methicillin-resistant Staphyloccocus aureus) epidemic is fueling antibiotic resistance globally and MRSA infections...More \232aMesothelioma Compensation Center Now Urges Diagnosed Electrical or Public Utility Workers to Call for Immediate Access to The Nation's Most Skilled Compensation Lawyers
Mesothelioma Compensation Center Now Urges Diagnosed Electrical or Public Utility Workers to Call for Immediate Access to The Nation's Most Skilled Compensation Lawyers
The Mesothelioma Compensation Center says, "We are one of the only groups in the nation that specializes in assisting electrical and public utility workers who have been diagnosed with mesothelioma. What we want is to see...More \232aThe Mesothelioma Compensation Center says, "We are one of the only groups in the nation that specializes in assisting electrical and public utility workers who have been diagnosed with mesothelioma. What we want is to see...More \232aBioPoint Earns Spot on Prestigious Inc. 5000 List of Fastest-Growing Private Companies for Third Straight Year
BioPoint Earns Spot on Prestigious Inc. 5000 List of Fastest-Growing Private Companies for Third Straight Year
This year's edition of the Inc. 5000 features a now-familiar name: BioPoint (http://biopointinc.com/), a global leader in life sciences workforce solutions, has made the list for the third year in a row. Now in its...More \232aThis year's edition of the Inc. 5000 features a now-familiar name: BioPoint (http://biopointinc.com/), a global leader in life sciences workforce solutions, has made the list for the third year in a row. Now in its...More \232aCommercial Application Segment to Dominate in Terms of Value in the Global Small Molecule API Market
Commercial Application Segment to Dominate in Terms of Value in the Global Small Molecule API Market
An exhaustive market evaluation put forth by Future Market Insights on the small molecule API market in a new research study titled "Small Molecule API Market: Global Industry Analysis 2012-2016 & Opportunity...More \232aAn exhaustive market evaluation put forth by Future Market Insights on the small molecule API market in a new research study titled "Small Molecule API Market: Global Industry Analysis 2012-2016 & Opportunity...More \232aWhich CNY Hospital was Ranked Among Best in State?
Which CNY Hospital was Ranked Among Best in State?
St. Joseph's Health Hospital has been recognized for the third consecutive year as a "Best Regional Hospital" and ranked #9 in New York State by U.S. News & World Report (up from its #13 ranking last year).More \232aSt. Joseph's Health Hospital has been recognized for the third consecutive year as a "Best Regional Hospital" and ranked #9 in New York State by U.S. News & World Report (up from its #13 ranking last year).More \232aINSIGHTEC Announces Expanded Reach of MR-Guided Focused Ultrasound
INSIGHTEC Announces Expanded Reach of MR-Guided Focused Ultrasound
INSIGHTEC announced today that worldwide adoption of MR-guided focused ultrasound continues to gain momentum as Exablate Neuro patient treatment numbers surpass the 1000 mark. Medical facilities are ramping up their...More \232aINSIGHTEC announced today that worldwide adoption of MR-guided focused ultrasound continues to gain momentum as Exablate Neuro patient treatment numbers surpass the 1000 mark. Medical facilities are ramping up their...More \232aOmnicell Announces Enhancements to its Patient Management Access Portal (PMAP) for Improved Patient Adherence and Pharmacy Workflow
Omnicell Announces Enhancements to its Patient Management Access Portal (PMAP) for Improved Patient Adherence and Pharmacy Workflow
Omnicell, Inc. (NASDAQ: OMCL) today announced four new enhancements to its Patient Management Access Portal (PMAP)-a single, web-based portal that hosts functionality to guide and track patient notes, interventions, and...More \232aOmnicell, Inc. (NASDAQ: OMCL) today announced four new enhancements to its Patient Management Access Portal (PMAP)-a single, web-based portal that hosts functionality to guide and track patient notes, interventions, and...More \232aCorporate Whistleblower Center Now Urges Hospitalists or ER Doctors to Call Them About Rewards if Their Hospital Employer is Overcharging Medicare For Needless Procedures
Corporate Whistleblower Center Now Urges Hospitalists or ER Doctors to Call Them About Rewards if Their Hospital Employer is Overcharging Medicare For Needless Procedures
The Corporate Whistleblower Center says, "We are urging hospitalists or ER doctors to call us anytime at 866-714-6466 if their hospital is gouging Medicare with up-coded billing or unnecessary medical procedures. As we...More \232aThe Corporate Whistleblower Center says, "We are urging hospitalists or ER doctors to call us anytime at 866-714-6466 if their hospital is gouging Medicare with up-coded billing or unnecessary medical procedures. As we...More \232aInvestors Eye Sweet Spots in Canada's Booming Cannabis Market
Investors Eye Sweet Spots in Canada's Booming Cannabis Market
Canada is the mecca of the North American cannabis market, boasting legalization in every province and an array of investment opportunities, such as ABcann Global Corporation (TSX.V: ABCN) (OTC: ABCCF), (ABcann PROFILE) a...More \232aCanada is the mecca of the North American cannabis market, boasting legalization in every province and an array of investment opportunities, such as ABcann Global Corporation (TSX.V: ABCN) (OTC: ABCCF), (ABcann PROFILE) a...More \232aTrovagene's PLK1 Inhibitor PCM-075, in Preclinical AML Data, Significantly Enhances the Efficacy of a FLT3 inhibitor in Combination Therapy
Trovagene's PLK1 Inhibitor PCM-075, in Preclinical AML Data, Significantly Enhances the Efficacy of a FLT3 inhibitor in Combination Therapy
Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced positive data from a preclinical in-vivo study examining the combination of their PLK1 inhibitor, PCM-075, with a leading...More \232aTrovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced positive data from a preclinical in-vivo study examining the combination of their PLK1 inhibitor, PCM-075, with a leading...More \232aArab Palestinian Investment Company (APIC) Achieved Net Profits after Tax of USD 7.9 Million in the First Half of 2017, a Growth of 25.4% Year on Year
Arab Palestinian Investment Company (APIC) Achieved Net Profits after Tax of USD 7.9 Million in the First Half of 2017, a Growth of 25.4% Year on Year
Tarek Aggad, Chairman and CEO of Arab Palestinian Investment Company (APIC) announced that the group achieved net profits after tax of USD 7.9 million in the first half of 2017, a growth of 25.4% year on year, while net...More \232aTarek Aggad, Chairman and CEO of Arab Palestinian Investment Company (APIC) announced that the group achieved net profits after tax of USD 7.9 million in the first half of 2017, a growth of 25.4% year on year, while net...More \232aPolyPid Ltd. Completes Enrollment in Phase Ib/II Study of D-PLEX™ in Post-Cardiac Surgery Sternal Infection
PolyPid Ltd. Completes Enrollment in Phase Ib/II Study of D-PLEX™ in Post-Cardiac Surgery Sternal Infection
PolyPid Ltd., a clinical-stage biopharmaceutical company with an initial focus on the prevention and treatment of post-surgical site infections, today announced the completion of enrollment in its Phase Ib/II study of...More \232aPolyPid Ltd., a clinical-stage biopharmaceutical company with an initial focus on the prevention and treatment of post-surgical site infections, today announced the completion of enrollment in its Phase Ib/II study of...More \232aGlobal Radiopharmaceuticals Market to Grow at a CAGR of 9% by 2021: Rising Burden of the Neurological Disorders
Global Radiopharmaceuticals Market to Grow at a CAGR of 9% by 2021: Rising Burden of the Neurological Disorders
The "Global Radiopharmaceuticals Market 2017-2021" report has been added to Research and Markets' offering. The global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021. The report,...More \232aThe "Global Radiopharmaceuticals Market 2017-2021" report has been added to Research and Markets' offering. The global radiopharmaceuticals market to grow at a CAGR of 9.02% during the period 2017-2021. The report,...More \232aBiotech Stock Performance Review -- Aralez Pharma, Arena Pharma, Arrowhead Pharma, and Aviragen Therapeutics
Biotech Stock Performance Review -- Aralez Pharma, Arena Pharma, Arrowhead Pharma, and Aviragen Therapeutics
If you want a Stock Review on ARLZ, ARNA, ARWR, or AVIR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Companies in the Biotech space are engaged in the research...More \232aIf you want a Stock Review on ARLZ, ARNA, ARWR, or AVIR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Companies in the Biotech space are engaged in the research...More \232aBreakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma
Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma
If you want a Stock Review on DEPO, SGYP, NVO, or SCLN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has issued research reports on...More \232aIf you want a Stock Review on DEPO, SGYP, NVO, or SCLN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. DailyStockTracker.com has issued research reports on...More \232a$1.21 Billion Medical Power Supply Market 2017 - Global Forecast to 2022
$1.21 Billion Medical Power Supply Market 2017 - Global Forecast to 2022
The "Medical Power Supply Market by Current Type (AC-DC Power Supply), Application (Monitoring Equipment (MRI, ECG, EEG, PET, Multiparameter Monitor, Ultrasound, X-ray, MEG)), Construction (Enclosed, External), Power...More \232aThe "Medical Power Supply Market by Current Type (AC-DC Power Supply), Application (Monitoring Equipment (MRI, ECG, EEG, PET, Multiparameter Monitor, Ultrasound, X-ray, MEG)), Construction (Enclosed, External), Power...More \232aGlobal Full-size Mobile C-arms Market to Grow at a CAGR of 4%, 2017-2021 with GE Healthcare, Philips Healthcare, Shimadzu & Ziehm Imaging Dominating
Global Full-size Mobile C-arms Market to Grow at a CAGR of 4%, 2017-2021 with GE Healthcare, Philips Healthcare, Shimadzu & Ziehm Imaging Dominating
The "Global Full-size Mobile C-arms Market 2017-2021" report has been added to Research and Markets' offering. The global full-size mobile C-arms market to grow at a CAGR of 4.09% during the period 2017-2021. The...More \232aThe "Global Full-size Mobile C-arms Market 2017-2021" report has been added to Research and Markets' offering. The global full-size mobile C-arms market to grow at a CAGR of 4.09% during the period 2017-2021. The...More \232aFDA Accepts Medivir´s IND Application for MIV-711, Enabling Clinical Development in the US
FDA Accepts Medivir´s IND Application for MIV-711, Enabling Clinical Development in the US
Medivir AB (Nasdaq Stockholm: MVIR) announces today that the Investigational New Drug (IND) application for MIV-711 has been accepted and the IND is now open with the FDA (U.S. Food and Drug Administration).More \232aMedivir AB (Nasdaq Stockholm: MVIR) announces today that the Investigational New Drug (IND) application for MIV-711 has been accepted and the IND is now open with the FDA (U.S. Food and Drug Administration).More \232aGlobal Huntington's Disease Therapeutics Market Growth at CAGR of 14.75%, 2017-2021 - Key Vendors are F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology & Teva Pharmaceutical
Global Huntington's Disease Therapeutics Market Growth at CAGR of 14.75%, 2017-2021 - Key Vendors are F. Hoffmann-La Roche, H. Lundbeck, Prana Biotechnology & Teva Pharmaceutical
The "Global Huntington's Disease Therapeutics Market 2017-2021" report has been added to Research and Markets' offering. The global huntington's disease therapeutics market to grow at a CAGR of 14.75% during...More \232aThe "Global Huntington's Disease Therapeutics Market 2017-2021" report has been added to Research and Markets' offering. The global huntington's disease therapeutics market to grow at a CAGR of 14.75% during...More \232aChildren's National part of pediatric cancer research collective awarded millions by NIH
Children's National part of pediatric cancer research collective awarded millions by NIH
Children's National Health System is a member of a public-private research collective that was awarded up to $14.8 million from the National Institutes of Health (NIH) to launch a data resource center for cancer...More \232aChildren's National Health System is a member of a public-private research collective that was awarded up to $14.8 million from the National Institutes of Health (NIH) to launch a data resource center for cancer...More \232aIntec Pharma Announces Proposed Public Offering of Ordinary Shares
Intec Pharma Announces Proposed Public Offering of Ordinary Shares
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) today announced the launch of an underwritten public offering of its ordinary shares. In connection with this offering, Intec Pharma also intends to grant the underwriters a...More \232aIntec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) today announced the launch of an underwritten public offering of its ordinary shares. In connection with this offering, Intec Pharma also intends to grant the underwriters a...More \232aSerra Ventures Invests in CureMatch
Serra Ventures Invests in CureMatch
CureMatch, a digital health company focusing on personalized medicine and combination therapy in oncology, today announced that it has closed its bridge round to Series A financing.More \232aCureMatch, a digital health company focusing on personalized medicine and combination therapy in oncology, today announced that it has closed its bridge round to Series A financing.More \232aFrost & Sullivan Awards Akonni Biosystems for its Groundbreaking TruDiagnosis® Molecular Diagnostics Platform
Frost & Sullivan Awards Akonni Biosystems for its Groundbreaking TruDiagnosis® Molecular Diagnostics Platform
Based on its recent analysis of microarrays in molecular diagnostics (MDx), Frost & Sullivan recognizes Akonni Biosystems, Inc. with the 2017 North America Frost & Sullivan Award for New Product Innovation....More \232aBased on its recent analysis of microarrays in molecular diagnostics (MDx), Frost & Sullivan recognizes Akonni Biosystems, Inc. with the 2017 North America Frost & Sullivan Award for New Product Innovation....More \232a$5.8 Billion Hearing Implants and Biomaterials Market, 2023
$5.8 Billion Hearing Implants and Biomaterials Market, 2023
The "Hearing Implants and Biomaterials: Market Shares, Strategies, and Forecasts, Worldwide 2017 to 2023" report from Wintergreen Research, Inc has been added to Research and Markets' offering. 'Hearing Implants...More \232aThe "Hearing Implants and Biomaterials: Market Shares, Strategies, and Forecasts, Worldwide 2017 to 2023" report from Wintergreen Research, Inc has been added to Research and Markets' offering. 'Hearing Implants...More \232aMetacrine Announces Collaboration on Development of FGF1 Variants for Glucose Lowering and Improving Insulin Sensitivity
Metacrine Announces Collaboration on Development of FGF1 Variants for Glucose Lowering and Improving Insulin Sensitivity
Metacrine, Inc., an innovative biotechnology company focused on drug development for metabolic diseases, announced it has entered a collaboration with Novo Nordisk A/S to develop Fibroblast Growth Factor 1 ("FGF1")...More \232aMetacrine, Inc., an innovative biotechnology company focused on drug development for metabolic diseases, announced it has entered a collaboration with Novo Nordisk A/S to develop Fibroblast Growth Factor 1 ("FGF1")...More \232aCryoport Launches - Cryoport. Certified. Cool.
Cryoport Launches - Cryoport. Certified. Cool.
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company dedicated to the life sciences industry, today announced it has expanded its portfolio of cold chain logistics solutions...More \232aCryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Company"), the world's leading cryogenic logistics company dedicated to the life sciences industry, today announced it has expanded its portfolio of cold chain logistics solutions...More \232aAccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement
AccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement
AccuGenomics, Inc., a diagnostic company based in Wilmington, NC, today announced that the company has provided an AccuKit to the HIV Cure Center at the University of North Carolina at Chapel Hill and to Qura Therapeutics...More \232aAccuGenomics, Inc., a diagnostic company based in Wilmington, NC, today announced that the company has provided an AccuKit to the HIV Cure Center at the University of North Carolina at Chapel Hill and to Qura Therapeutics...More \232aivWatch Achieves ISO 13485 Certification: Provides Foundation for International Distribution
ivWatch Achieves ISO 13485 Certification: Provides Foundation for International Distribution
ivWatch LLC, a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy, today announced receipt of its ISO 13485 Certification, the global standard for medical device quality...More \232aivWatch LLC, a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy, today announced receipt of its ISO 13485 Certification, the global standard for medical device quality...More \232aTracking Trends in Biotechnology
Tracking Trends in Biotechnology
The healthcare sector is made up of several different industries, from pharmaceuticals to biotechnology to health insurance. Making predictions in this sector can be difficult as there are many variables working with and...More \232aThe healthcare sector is made up of several different industries, from pharmaceuticals to biotechnology to health insurance. Making predictions in this sector can be difficult as there are many variables working with and...More \232aPublication in EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins and Tumors
Publication in EMBO Molecular Medicine Demonstrates CureVac's Proprietary mRNA Technology Enables Antibody Mediated Therapies Against Infectious Agents, Toxins and Tumors
CureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced the publication of a study in the peer-reviewed journal EMBO Molecular Medicine, demonstrating the utility of CureVac's...More \232aCureVac AG, a fully-integrated biotechnology company pioneering mRNA-based drugs, today announced the publication of a study in the peer-reviewed journal EMBO Molecular Medicine, demonstrating the utility of CureVac's...More \232aSpherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board
Spherix Announces the Addition of Dr. Scott T. Tagawa to Company's Technology Advisory Board
Spherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to the fostering of technology, today announced the addition of Dr. Scott T. Tagawa to the...More \232aSpherix Incorporated ("Spherix" or the "Company") (NASDAQ: SPEX), an intellectual property development company committed to the fostering of technology, today announced the addition of Dr. Scott T. Tagawa to the...More \232aPhilips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
Philips announces agreement with Lakeland Health for advanced monitoring to improve patient safety
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an agreement with Lakeland Health to integrate the Philips IntelliVue Guardian Solution with automated Early Warning Scoring (EWS)...More \232aRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an agreement with Lakeland Health to integrate the Philips IntelliVue Guardian Solution with automated Early Warning Scoring (EWS)...More \232aHealthWell Foundation Opens Fund to Assist Medicare Patients with Acute Myeloid Leukemia
HealthWell Foundation Opens Fund to Assist Medicare Patients with Acute Myeloid Leukemia
The HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new Acute Myeloid Leukemia (AML) fund to provide copayment and premium assistance...More \232aThe HealthWell Foundation®, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new Acute Myeloid Leukemia (AML) fund to provide copayment and premium assistance...More \232aCancer Treatment Centers of America® and Foundation Medicine® Join Forces to Advance Precision Cancer Treatment
Cancer Treatment Centers of America® and Foundation Medicine® Join Forces to Advance Precision Cancer Treatment
Cancer Treatment Centers of America® (CTCA) and Foundation Medicine® today announced a new element to their longstanding partnership to increase awareness of advancements in genomic testing and precision medicine in...More \232aCancer Treatment Centers of America® (CTCA) and Foundation Medicine® today announced a new element to their longstanding partnership to increase awareness of advancements in genomic testing and precision medicine in...More \232aAphria Announces $11.5 Million Strategic Investment In Scientus Pharma
Aphria Announces $11.5 Million Strategic Investment In Scientus Pharma
Innovative extraction process opens door to future cannabinoid based medical productsMore \232aInnovative extraction process opens door to future cannabinoid based medical productsMore \232aBionik Laboratories Reports First Quarter Fiscal Year 2018 Financial Results
Bionik Laboratories Reports First Quarter Fiscal Year 2018 Financial Results
Bionik Laboratories Corp. (OTCQX: BNKL) ("Bionik" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from...More \232aBionik Laboratories Corp. (OTCQX: BNKL) ("Bionik" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from...More \232aLexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today additional positive data from the pivotal Phase 3 inTandem2 study of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor. It was previously...More \232aLexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today additional positive data from the pivotal Phase 3 inTandem2 study of sotagliflozin, an investigational dual SGLT1 and SGLT2 inhibitor. It was previously...More \232aNew SpineScreen app helps parents detect signs of scoliosis in kids
New SpineScreen app helps parents detect signs of scoliosis in kids
Parents can now check their child's spine for possible signs of scoliosis with the new app SpineScreen developed by Shriners Hospitals for Children®. Available for free on the App Store and Google Play, SpineScreen...More \232aParents can now check their child's spine for possible signs of scoliosis with the new app SpineScreen developed by Shriners Hospitals for Children®. Available for free on the App Store and Google Play, SpineScreen...More \232aSierra Oncology Establishes Distinguished DNA Damage Response Advisory Committee
Sierra Oncology Establishes Distinguished DNA Damage Response Advisory Committee
- Leading experts in DDR biology, chemistry and medicine to help maximize the potential clinical and commercial opportunities for Sierra's drug candidates –More \232a- Leading experts in DDR biology, chemistry and medicine to help maximize the potential clinical and commercial opportunities for Sierra's drug candidates –More \232aGeneNews Announces Q2-2017 Financial Results & Provides Progress Update
GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
Have now enrolled more than 2,000 medical practices in the Innovative Diagnostic Laboratory ("IDL") systemMore than 1,800 tests were processed by IDL in the quarter, which is more than three times the level in Q1Expanded...More \232aHave now enrolled more than 2,000 medical practices in the Innovative Diagnostic Laboratory ("IDL") systemMore than 1,800 tests were processed by IDL in the quarter, which is more than three times the level in Q1Expanded...More \232aSuperdisintegrants Market Worth $487.0 Million by 2025 | CAGR 7.2%: Grand View Research, Inc.
Superdisintegrants Market Worth $487.0 Million by 2025 | CAGR 7.2%: Grand View Research, Inc.
The global superdisintegrants market is expected to reach USD 487.0 million by 2025, according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into...More \232aThe global superdisintegrants market is expected to reach USD 487.0 million by 2025, according to a new report by Grand View Research, Inc. Superdisintegrants help in the disintegration of tablet or capsule content into...More \232aThe Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and Launch of a Patient Driven Clinical Study in ROS1 Positive Cancer
The Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and Launch of a Patient Driven Clinical Study in ROS1 Positive Cancer
The Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology (NASDAQ: CSBR), and the ROS1ders (voiced as "ross wonders") announce a preclinical study that will develop new models of cancers expressing a ROS1 gene...More \232aThe Addario Lung Cancer Medical Institute (ALCMI), Champions Oncology (NASDAQ: CSBR), and the ROS1ders (voiced as "ross wonders") announce a preclinical study that will develop new models of cancers expressing a ROS1 gene...More \232aBrainStorm Announces Second Quarter 2017 Financial Results
BrainStorm Announces Second Quarter 2017 Financial Results
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced financial results for the second quarter ending June 30, 2017.More \232aBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced financial results for the second quarter ending June 30, 2017.More \232aESSA Pharma Provides Business Update and Announces Financial Results for the Fiscal Third Quarter Ended June 30, 2017
ESSA Pharma Provides Business Update and Announces Financial Results for the Fiscal Third Quarter Ended June 30, 2017
HOUSTON, TX and VANCOUVER, Aug. 14, 2017 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI, NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate...More \232aHOUSTON, TX and VANCOUVER, Aug. 14, 2017 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX: EPI, NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for prostate...More \232aAmneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product
Amneal Pharmaceuticals Issues Voluntary Nationwide Recall of Lorazepam Oral Concentrate, USP 2mg/mL, Due to Misprinted Dosing Droppers Supplied with the Product
Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is...More \232aAmneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings. The Lorazepam Oral Concentrate, USP 2mg/mL, product is...More \232aChina Human Vaccine Markets 2017 - Forecasts to 2021
China Human Vaccine Markets 2017 - Forecasts to 2021
The "China Human Vaccine Industry Report, 2017-2021" report has been added to Research and Markets' offering. Pushed by the two-child policy, population aging, and launching of new vaccines, the vaccine industry in...More \232aThe "China Human Vaccine Industry Report, 2017-2021" report has been added to Research and Markets' offering. Pushed by the two-child policy, population aging, and launching of new vaccines, the vaccine industry in...More \232aWorld Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy Research Report 2017
World Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy Research Report 2017
The "Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy" report has been added to Research and Markets' offering. Cardiac Marker Analyzer Product Analysis, Cardiac...More \232aThe "Cardiac Marker Analyzer Product Analysis, Cardiac Marker Companies Business & Marketing Strategy" report has been added to Research and Markets' offering. Cardiac Marker Analyzer Product Analysis, Cardiac...More \232aArray BioPharma Appoints Curtis Oltmans As General Counsel
Array BioPharma Appoints Curtis Oltmans As General Counsel
Array BioPharma (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced it has...More \232aArray BioPharma (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced it has...More \232aLeidos and Biosortia Pharmaceuticals Execute Memorandum of Understanding
Leidos and Biosortia Pharmaceuticals Execute Memorandum of Understanding
Leidos (NYSE: LDOS), a FORTUNE 500® science and technology company, has signed a Memorandum of Understanding (MOU) with Biosortia Pharmaceuticals to explore creating a new business relationship with a focus on identifying...More \232aLeidos (NYSE: LDOS), a FORTUNE 500® science and technology company, has signed a Memorandum of Understanding (MOU) with Biosortia Pharmaceuticals to explore creating a new business relationship with a focus on identifying...More \232aGlobal Kinetics Corp Secures First US Patent For Its Digital Health System
Global Kinetics Corp Secures First US Patent For Its Digital Health System
The technology allows objective measurement of symptoms of Parkinson's diseaseMore \232aThe technology allows objective measurement of symptoms of Parkinson's diseaseMore \232aStudy Hints at Experimental Therapy for Heart Fibrosis
Study Hints at Experimental Therapy for Heart Fibrosis
Researchers report encouraging preclinical results as they pursue elusive therapeutic strategies to repair scarred and poorly functioning heart tissues after cardiac injury – describing an experimental molecular treatment...More \232aResearchers report encouraging preclinical results as they pursue elusive therapeutic strategies to repair scarred and poorly functioning heart tissues after cardiac injury – describing an experimental molecular treatment...More \232aGlobal Ostomy Care Accessories Market - Analysis, Technologies & Forecasts to 2021 - Driven by an Increase in Online Sales
Global Ostomy Care Accessories Market - Analysis, Technologies & Forecasts to 2021 - Driven by an Increase in Online Sales
The "Global Ostomy Care Accessories Market 2017-2021" report has been added to Research and Markets' offering. The global ostomy care accessories market to grow at a CAGR of 5.91% during the period 2017-2021. Global...More \232aThe "Global Ostomy Care Accessories Market 2017-2021" report has been added to Research and Markets' offering. The global ostomy care accessories market to grow at a CAGR of 5.91% during the period 2017-2021. Global...More \232aWolf Administration To Distribute Free Potassium Iodide August 24 for Pennsylvanians Near the State's Five Nuclear Power Plants
Wolf Administration To Distribute Free Potassium Iodide August 24 for Pennsylvanians Near the State's Five Nuclear Power Plants
As part of its annual distribution to replace expired potassium iodide, or KI tablets, the Department of Health will offer free tablets on Thursday, August 24, to Pennsylvanians who live or work within 10 miles of the...More \232aAs part of its annual distribution to replace expired potassium iodide, or KI tablets, the Department of Health will offer free tablets on Thursday, August 24, to Pennsylvanians who live or work within 10 miles of the...More \232aGlobal Humanized Mouse Model Market to Grow at a CAGR of 9.8% by 2021: Key Vendors are genOway, Horizon Discovery, Taconic Biosciences & Jackson Laboratory
Global Humanized Mouse Model Market to Grow at a CAGR of 9.8% by 2021: Key Vendors are genOway, Horizon Discovery, Taconic Biosciences & Jackson Laboratory
The "Global Humanized Mouse Model Market 2017-2021" report has been added to Research and Markets' offering. The global humanized mouse model market to grow at a CAGR of 9.84% during the period 2017-2021. Global...More \232aThe "Global Humanized Mouse Model Market 2017-2021" report has been added to Research and Markets' offering. The global humanized mouse model market to grow at a CAGR of 9.84% during the period 2017-2021. Global...More \232aGlobal Orthopedic Operating Tables Market to Grow at a CAGR of 5% by 2021: Analysis By Operation Type, End User & Geography
Global Orthopedic Operating Tables Market to Grow at a CAGR of 5% by 2021: Analysis By Operation Type, End User & Geography
The "Global Orthopedic Operating Tables Market 2017-2021" report has been added to Research and Markets' offering. The global orthopedic operating tables market to grow at a CAGR of 5.08 % during the period 2017-2021....More \232aThe "Global Orthopedic Operating Tables Market 2017-2021" report has been added to Research and Markets' offering. The global orthopedic operating tables market to grow at a CAGR of 5.08 % during the period 2017-2021....More \232aBreakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice
Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice
Obesity is a known risk factor for pancreatic cancer, a disease with a five-year survival of only 9 percent, but little is known about how, or if, the disease behaves differently in obese vs. lean individuals. In a study...More \232aObesity is a known risk factor for pancreatic cancer, a disease with a five-year survival of only 9 percent, but little is known about how, or if, the disease behaves differently in obese vs. lean individuals. In a study...More \232aRegeneRx Collaborators Receive Notice of 'Intent to Grant' EU Patent for the Treatment of Peripheral Neuropathy
RegeneRx Collaborators Receive Notice of 'Intent to Grant' EU Patent for the Treatment of Peripheral Neuropathy
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent...More \232aRegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the European Patent...More \232aBiological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027
Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027
Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine The Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027:...More \232aMammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine The Biological Drug API Manufacturing Services World Industry and Market Predictions 2017-2027:...More \232aGlobal Neurointerventional Market 2017-2023 by Product Type, End-Users, and Regions
Global Neurointerventional Market 2017-2023 by Product Type, End-Users, and Regions
The "Global Neurointerventional Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering. The Global Neurointerventional Devices Market is estimated...More \232aThe "Global Neurointerventional Market Trends and Drivers, Restraints, and Opportunities 2017-2023" report has been added to Research and Markets' offering. The Global Neurointerventional Devices Market is estimated...More \232aBiocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has...More \232aBiocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, announces that it has...More \232aSynthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Synthorx Inc., a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment of Marcos Milla, Ph.D. as senior vice president of research.More \232aSynthorx Inc., a biotechnology company using synthetic biology to discover and develop novel protein therapeutics, announced today the appointment of Marcos Milla, Ph.D. as senior vice president of research.More \232aExpanding Orthopedics Inc. Granted Two Additional US Patents in the Expandable Interbody Domain
Expanding Orthopedics Inc. Granted Two Additional US Patents in the Expandable Interbody Domain
Expanding Orthopedics Inc. (EOI), a medical device company focused on developing and commercializing innovative expandable devices for spine surgery, is excited to announce that it has been granted two additional US...More \232aExpanding Orthopedics Inc. (EOI), a medical device company focused on developing and commercializing innovative expandable devices for spine surgery, is excited to announce that it has been granted two additional US...More \232aDarioHealth Reports Second Quarter 2017 Results
DarioHealth Reports Second Quarter 2017 Results
DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the three-month period ended June 30, 2017.More \232aDarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and operational results for the three-month period ended June 30, 2017.More \232aMabVax Therapeutics Holdings, Inc. Announces Pricing of Registered Direct Offering
MabVax Therapeutics Holdings, Inc. Announces Pricing of Registered Direct Offering
MabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today announced...More \232aMabVax Therapeutics Holdings, Inc. (Nasdaq: MBVX), a clinical-stage biotechnology company focused on the development of antibody-based products to address unmet medical needs in the treatment of cancer, today announced...More \232aEiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results
Eiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results
Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today financial results for the three months and six months ended June 30,...More \232aEiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today financial results for the three months and six months ended June 30,...More \232aBiondVax Receives Additional Grant Funding
BiondVax Receives Additional Grant Funding
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) (TASE: BVXV) announced today that the Israel Innovation Authority (IIA), formerly known as the Office of the Chief Scientist, agreed to fund upto 40% of a NIS 2.7 million...More \232aBiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) (TASE: BVXV) announced today that the Israel Innovation Authority (IIA), formerly known as the Office of the Chief Scientist, agreed to fund upto 40% of a NIS 2.7 million...More \232aCytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients
CytoSorbents Awarded $719,000 Grant To Acutely Stabilize Severe Burn Patients
CytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that it has been awarded a grant from the U.S. Army Medical Research and Materiel Command to...More \232aCytoSorbents Corporation (NASDAQ: CTSO), a leader in critical care immunotherapy specializing in blood purification, announced that it has been awarded a grant from the U.S. Army Medical Research and Materiel Command to...More \232aBiostage Reports 2017 Second Quarter Financial Results:
Biostage Reports 2017 Second Quarter Financial Results:
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancer, congenital abnormalities and other life-threatening conditions of the...More \232aBiostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancer, congenital abnormalities and other life-threatening conditions of the...More \232aAzita Saleki-Gerhardt to Join Entegris Board of Directors
Azita Saleki-Gerhardt to Join Entegris Board of Directors
Entegris, Inc. (NASDAQ: ENTG), a leading specialty materials provider, announced today that Azita Saleki-Gerhardt, Ph.D. will join the Entegris Board of Directors in the post of non-executive director. Currently, Dr....More \232aEntegris, Inc. (NASDAQ: ENTG), a leading specialty materials provider, announced today that Azita Saleki-Gerhardt, Ph.D. will join the Entegris Board of Directors in the post of non-executive director. Currently, Dr....More \232aPrometic and Shenzhen Royal Asset Management Close Transaction for Joint Venture and Licensing Rights to PBI-4050, PBI-4547 and PBI-4425 in China
Prometic and Shenzhen Royal Asset Management Close Transaction for Joint Venture and Licensing Rights to PBI-4050, PBI-4547 and PBI-4425 in China
Deal provides Prometic with an initial $33 million, of which $23 million receivable in H2 2017SRAM acquired a Chinese pharmaceutical company to serve as development and commercial platform LAVAL, QC, Aug. 14, 2017...More \232aDeal provides Prometic with an initial $33 million, of which $23 million receivable in H2 2017SRAM acquired a Chinese pharmaceutical company to serve as development and commercial platform LAVAL, QC, Aug. 14, 2017...More \232aStock Performance Review on Biotech Industry -- Blueprint Medicines, Calithera Biosciences, Concordia Intl., and Cytokinetics
Stock Performance Review on Biotech Industry -- Blueprint Medicines, Calithera Biosciences, Concordia Intl., and Cytokinetics
If you want a Stock Review on BPMC, CALA, CXRX, or CYTK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Friday, the NASDAQ Composite ended the day at 6,256.56,...More \232aIf you want a Stock Review on BPMC, CALA, CXRX, or CYTK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Friday, the NASDAQ Composite ended the day at 6,256.56,...More \232aCASI Pharmaceuticals Reports Second Quarter 2017 Financial Results
CASI Pharmaceuticals Reports Second Quarter 2017 Financial Results
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, today reported financial results for the three and six months...More \232aCASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, today reported financial results for the three and six months...More \232aBiohaven Pharmaceuticals Reports Second Quarter 2017 Financial And Business Results
Biohaven Pharmaceuticals Reports Second Quarter 2017 Financial And Business Results
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders,...More \232aBiohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders,...More \232aCanopy Growth Corporation Reports First Quarter Fiscal 2018 Financial Results
Canopy Growth Corporation Reports First Quarter Fiscal 2018 Financial Results
New presentation of per gram costs discloses separate cultivation to harvest, post-harvest and shipping and fulfillment costs, cost per gram to point of harvest was $0.76 per gram, the fourth consecutive quarter when the...More \232aNew presentation of per gram costs discloses separate cultivation to harvest, post-harvest and shipping and fulfillment costs, cost per gram to point of harvest was $0.76 per gram, the fourth consecutive quarter when the...More \232aSoligenix Receives $2.5M in Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine
Soligenix Receives $2.5M in Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...More \232aSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced...More \232aBreakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma
Breakfast Technical Briefing on Generic Drugs Stocks -- Horizon Pharma, Mylan, Neurocrine Biosciences, and Rigel Pharma
If you want a Stock Review on HZNP, MYL, NBIX, or RIGL then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The top fifty Generic Drugs producers had combined revenues...More \232aIf you want a Stock Review on HZNP, MYL, NBIX, or RIGL then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The top fifty Generic Drugs producers had combined revenues...More \232aBoard Review of Business Operations and Governance
Board Review of Business Operations and Governance
Novogen Ltd (ASX: NRT; NASDAQ: NVGN), an Australian oncology drug development company, is pleased to provide an update to investors on a review of business operations recently completed by the Board and management team....More \232aNovogen Ltd (ASX: NRT; NASDAQ: NVGN), an Australian oncology drug development company, is pleased to provide an update to investors on a review of business operations recently completed by the Board and management team....More \232aSinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
Sinovac Biotech Ltd. (NASDAQ: SVA)("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock Market ("NASDAQ") has accepted the Company's plan to...More \232aSinovac Biotech Ltd. (NASDAQ: SVA)("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that The NASDAQ Stock Market ("NASDAQ") has accepted the Company's plan to...More \232aThe Great Hall of China: double digit growth at CPhI China
The Great Hall of China: double digit growth at CPhI China
CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), closed in June 2017 with a very successful show, reporting...More \232aCPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), closed in June 2017 with a very successful show, reporting...More \232aDr. Reddy's (RDY) Alert: J&W Investigates Dr. Reddy's Laboratories Ltd.; Has Your Dr. Reddy's Investment Declined in Value?
Dr. Reddy's (RDY) Alert: J&W Investigates Dr. Reddy's Laboratories Ltd.; Has Your Dr. Reddy's Investment Declined in Value?
Shareholder rights law firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Dr. Reddy's Laboratories Ltd. (NYSE: RDY) and certain of its officers. Dr. Reddy's...More \232aShareholder rights law firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Dr. Reddy's Laboratories Ltd. (NYSE: RDY) and certain of its officers. Dr. Reddy's...More \232aFDA warns of potential contamination in multiple brands of drugs, dietary supplements
FDA warns of potential contamination in multiple brands of drugs, dietary supplements
The U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby...More \232aThe U.S. Food and Drug Administration is advising consumers and health care professionals not to use any liquid drug or dietary supplement products manufactured by PharmaTech LLC of Davie, Florida, and labeled by Rugby...More \232aGlobal Pharma App Benchmarking Report 2017 - Current Status of the App Publishing Activities of the Twelve Leading Pharma Companies
Global Pharma App Benchmarking Report 2017 - Current Status of the App Publishing Activities of the Twelve Leading Pharma Companies
The "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering. Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have...More \232aThe "Pharma App Benchmarking 2017" report has been added to Research and Markets' offering. Since the first report about the app publishing activities of leading Pharma companies was published in 2014, companies have...More \232aPharmaceutical Industry Utilizes Local Medical Information Groups to Support Affiliate Operations in Global Locations
Pharmaceutical Industry Utilizes Local Medical Information Groups to Support Affiliate Operations in Global Locations
Savvy pharmaceutical companies create local medical information groups within their affiliate operations around the world to more effectively address local inquiries about products.More \232aSavvy pharmaceutical companies create local medical information groups within their affiliate operations around the world to more effectively address local inquiries about products.More \232a
PR Newswire IndexMore>>
Entertainment News Releases via PRNewswire
Entertainment
Entertainment News Releases via PRNewswire
Travel
Travel News Releases via PRNewswire
Political Campaigns
Political Campaigns News Releases via PRNewswire
Medicine & Pharmaceuticals
Medicine & Pharmaceuticals News Releases via PRNewswire
Film & Motion Picture News Releases via PRNewswire
Film & Motion Picture
Film & Motion Picture News Releases via PRNewswire
Economic News and Analysis
Economic News Releases via PRNewswire
Computer Software
Computer Software News Releases via PRNewswire
Computer Networks
Computer Networks News Releases via PRNewswire
Computer Hardware
Computer Hardware News Releases via PRNewswire
Biotech News Releases via PRNewswire
Biotechnology
Biotechnology News Releases via PRNewswire
